TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $351 | -95.0% | 234 | -93.7% | 0.00% | – |
Q3 2022 | $7,000 | -84.4% | 3,699 | -61.9% | 0.00% | – |
Q4 2021 | $45,000 | -90.3% | 9,701 | -82.3% | 0.00% | – |
Q3 2021 | $466,000 | +85.7% | 54,728 | +258.6% | 0.00% | – |
Q2 2021 | $251,000 | -79.0% | 15,262 | -71.8% | 0.00% | – |
Q1 2021 | $1,194,000 | +2495.7% | 54,070 | +3533.7% | 0.00% | – |
Q4 2020 | $46,000 | +666.7% | 1,488 | +433.3% | 0.00% | – |
Q3 2020 | $6,000 | -92.4% | 279 | -94.6% | 0.00% | – |
Q2 2020 | $79,000 | +49.1% | 5,169 | -24.4% | 0.00% | – |
Q1 2020 | $53,000 | -74.3% | 6,835 | -52.7% | 0.00% | – |
Q4 2019 | $206,000 | +52.6% | 14,453 | +61.1% | 0.00% | – |
Q3 2019 | $135,000 | +487.0% | 8,972 | +461.8% | 0.00% | – |
Q2 2019 | $23,000 | +2200.0% | 1,597 | +4890.6% | 0.00% | – |
Q1 2019 | $1,000 | – | 32 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |